UnitedHealth Group Incorporated (NYSE:UNH) Stock Position Reduced by Janus Henderson Group PLC

Janus Henderson Group PLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.2% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,958,299 shares of the healthcare conglomerate’s stock after selling 11,028 shares during the quarter. UnitedHealth Group comprises approximately 1.5% of Janus Henderson Group PLC’s holdings, making the stock its 9th biggest holding. Janus Henderson Group PLC owned approximately 0.54% of UnitedHealth Group worth $2,899,000,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Kathleen S. Wright Associates Inc. acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at $27,000. Macroview Investment Management LLC boosted its stake in shares of UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares in the last quarter. Bbjs Financial Advisors LLC acquired a new stake in UnitedHealth Group in the 2nd quarter valued at $31,000. Global Wealth Strategies & Associates increased its position in shares of UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares during the period. Finally, Signature Resources Capital Management LLC raised its holdings in shares of UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 18 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.3 %

NYSE UNH opened at $608.48 on Tuesday. The firm’s fifty day moving average price is $585.43 and its 200 day moving average price is $556.65. The company has a market capitalization of $559.97 billion, a price-to-earnings ratio of 39.64, a price-to-earnings-growth ratio of 1.79 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.56 EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.38%. UnitedHealth Group’s payout ratio is 54.72%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on UNH shares. Morgan Stanley lowered their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, November 20th. Bank of America dropped their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. HSBC cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Finally, KeyCorp started coverage on UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 price target for the company. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $618.26.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.